Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Fauchère JL[au]:

Receptors and antagonists for substance P and related peptides. Regoli D et al. Pharmacol Rev. (1994)

Comparative evaluation of 29 commercial Helicobacter pylori serological kits. Burucoa C et al. Helicobacter. (2013)

[Medical aspects of urinary tract infections]. Dupont B et al. J Urol (Paris). (1983)

Search results

Items: 1 to 50 of 156

1.

Comparative evaluation of 29 commercial Helicobacter pylori serological kits.

Burucoa C, Delchier JC, Courillon-Mallet A, de Korwin JD, Mégraud F, Zerbib F, Raymond J, Fauchère JL.

Helicobacter. 2013 Jun;18(3):169-79. doi: 10.1111/hel.12030. Epub 2013 Jan 14.

PMID:
23316886
2.

Detection of Campylobacter jejuni by culture and real-time PCR in a French cohort of patients with Guillain-Barre syndrome.

Sivadon-Tardy V, Orlikowski D, Porcher R, Ronco E, Caudie C, Roussi J, Fauchère JL, Mégraud F, Tabor H, Sharshar T, Annane D, Raphaël JC, Gaillard JL.

J Clin Microbiol. 2010 Jun;48(6):2278-81. doi: 10.1128/JCM.00381-10. Epub 2010 Apr 21.

3.

S38151 [p-guanidinobenzoyl-[Des-Gly(10)]-MCH(7-17)] is a potent and selective antagonist at the MCH(1) receptor and has anti-feeding properties in vivo.

Audinot V, Zuana OD, Fabry N, Ouvry C, Nosjean O, Henlin JM, Fauchère JL, Boutin JA.

Peptides. 2009 Nov;30(11):1997-2007. doi: 10.1016/j.peptides.2009.07.007. Epub 2009 Jul 18.

PMID:
19619599
4.

Proteomic Helicobacter pylori biomarkers discriminative of low-grade gastric MALT lymphoma and duodenal ulcer.

Bernarde C, Khoder G, Lehours P, Burucoa C, Fauchère JL, Delchier JC, Mégraud F, Atanassov C.

Proteomics Clin Appl. 2009 Jun;3(6):672-81. doi: 10.1002/prca.200800158.

PMID:
21136979
5.

Proteomic Helicobacter pylori biomarkers discriminating between duodenal ulcer and gastric cancer.

Khoder G, Yamaoka Y, Fauchère JL, Burucoa C, Atanassov C.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Apr 15;877(11-12):1193-9. doi: 10.1016/j.jchromb.2009.03.003. Epub 2009 Mar 11.

6.

Quadruplex real-time PCR assay using allele-specific scorpion primers for detection of mutations conferring clarithromycin resistance to Helicobacter pylori.

Burucoa C, Garnier M, Silvain C, Fauchère JL.

J Clin Microbiol. 2008 Jul;46(7):2320-6. doi: 10.1128/JCM.02352-07. Epub 2008 May 7.

7.

Antimicrobial resistance data on 16,756 Streptococcus pneumoniae isolates in 1999: A Pan-Regional Multicenter Surveillance Study in France.

Demachy MC, Vernet-Garnier V, Cottin J, Cattier B, Chardon H, Chomarat M, Dupont P, Fauchere JL, Fosse T, Laaberki MF, Laurans G, Lemozy J, Maugein J, Murbach V, Pechinot A, Romaszko JP, Roussel-Delvallez M, Thoreux PH, Vaucel J, Vergnaud M, Weber M, Ploy MC.

Microb Drug Resist. 2005 Winter;11(4):323-9.

PMID:
16359191
8.

[Prevalence and characteristics of Guillain-Barré syndromes associated with Campylobacter jejuni and cytomegalovirus in greater Paris].

Sivadon V, Orlikowski D, Rozenberg F, Quincampoix JC, Caudie C, Durand MC, Fauchère JL, Sharshar T, Raphaël JC, Gaillard JL.

Pathol Biol (Paris). 2005 Oct-Nov;53(8-9):536-8. Epub 2005 Aug 3. French.

PMID:
16084033
9.

T2182C mutation is not associated with clarithromycin resistance in Helicobacter pylori.

Burucoa C, Landron C, Garnier M, Fauchère JL.

Antimicrob Agents Chemother. 2005 Feb;49(2):868; author reply 868-70. No abstract available.

10.

Polyphosphate kinase: a new colonization factor of Helicobacter pylori.

Ayraud S, Janvier B, Labigne A, Ecobichon C, Burucoa C, Fauchère JL.

FEMS Microbiol Lett. 2005 Feb 1;243(1):45-50.

11.

A potent and selective NPY Y5 antagonist reduces food intake but not through blockade of the NPY Y5 receptor.

Della-Zuana O, Revereault L, Beck-Sickinger A, Monge A, Caignard DH, Fauchère JL, Henlin JM, Audinot V, Boutin JA, Chamorro S, Félétou M, Levens N.

Int J Obes Relat Metab Disord. 2004 Apr;28(4):628-39.

PMID:
14758341
12.

Synthesis of N,N'-disubstituted 3-aminobenzo[c] and [d]azepin-2-ones as potent and specific farnesyl transferase inhibitors.

Le Diguarher T, Ortuno JC, Shanks D, Guilbaud N, Pierré A, Raimbaud E, Fauchère JL, Hickman JA, Tucker GC, Casara PJ.

Bioorg Med Chem Lett. 2004 Feb 9;14(3):767-71.

PMID:
14741286
13.

Second-line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies.

Lamouliatte H, Mégraud F, Delchier JC, Bretagne JF, Courillon-Mallet A, De Korwin JD, Fauchère JL, Labigne A, Fléjou JF, Barthelemy P; Multicentre Study Group.

Aliment Pharmacol Ther. 2003 Oct 15;18(8):791-7.

14.

Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADP.

Adam F, Verbeuren TJ, Fauchère JL, Guillin MC, Jandrot-Perrus M.

J Thromb Haemost. 2003 Apr;1(4):798-804.

15.

[Helicobacter pylori infection: prospective study for asymptomatic Tunisian children].

Maherzi A, Bouaziz Abed A, Fendri C, Oubich F, Koubaa C, Fauchere JL, Bousnina S.

Arch Pediatr. 2003 Mar;10(3):204-7. French.

PMID:
12829332
16.

Parallel liquid synthesis of N,N'-Disubstituted 3-amino azepin-2-ones as potent and specific farnesyl transferase inhibitors.

Le Diguarher T, Ortuno JC, Dorey G, Shanks D, Guilbaud N, Pierré A, Fauchère JL, Hickman JA, Tucker GC, Casara PJ.

Bioorg Med Chem. 2003 Jul 17;11(14):3193-204.

PMID:
12818682
17.

Colonization of lower respiratory tract with anaerobic bacteria in mechanically ventilated patients.

Robert R, Grollier G, Frat JP, Godet C, Adoun M, Fauchère JL, Doré P.

Intensive Care Med. 2003 Jul;29(7):1062-8. Epub 2003 Apr 16. Erratum in: Intensive Care Med. 2003 Nov;29(11):2107.

PMID:
12698243
18.

Modification in the ppk gene of Helicobacter pylori during single and multiple experimental murine infections.

Ayraud S, Janvier B, Salaun L, Fauchère JL.

Infect Immun. 2003 Apr;71(4):1733-9.

19.
20.

SVK14 cells express an MCH binding site different from the MCH1 or MCH2 receptor.

Audinot V, Lahaye C, Suply T, Rovère-Jovène C, Rodriguez M, Nicolas JP, Beauverger P, Cardinaud B, Galizzi JP, Fauchère JL, Nahon JL, Boutin JA.

Biochem Biophys Res Commun. 2002 Jul 26;295(4):841-8.

PMID:
12127971
21.

Melanin-concentrating hormone and its receptors: state of the art.

Boutin JA, Suply T, Audinot V, Rodriguez M, Beauverger P, Nicolas JP, Galizzi JP, Fauchère JL.

Can J Physiol Pharmacol. 2002 May;80(5):388-95. Review.

PMID:
12056544
22.

Change of pneumococcal resistance to antibiotics in adults between 1995 and 1997: a study in eight French counties.

Roussel-Delvallez M, Chardon H, Dupont MJ, Fosse T, Fauchere JL, Laurans G, Weber M, Maugein J.

Int J Antimicrob Agents. 2002 May;19(5):389-96.

PMID:
12007847
23.

Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori.

Grignon B, Tankovic J, Mégraud F, Glupczynski Y, Husson MO, Conroy MC, Emond JP, Loulergue J, Raymond J, Fauchère JL.

Microb Drug Resist. 2002 Spring;8(1):61-6.

PMID:
12002651
24.

Appetite suppression based on selective inhibition of NPY receptors.

Chamorro S, Della-Zuana O, Fauchère JL, Félétou M, Galizzi JP, Levens N.

Int J Obes Relat Metab Disord. 2002 Mar;26(3):281-98. Review.

PMID:
11896483
25.

Novel antigens of Helicobacter pylori correspond to ulcer-related antibody pattern of sera from infected patients.

Atanassov C, Pezennec L, d'Alayer J, Grollier G, Picard B, Fauchère JL.

J Clin Microbiol. 2002 Feb;40(2):547-52.

26.

Solid-phase synthesis of alpha-substituted 3-bisarylthio N-hydroxy propionamides as specific MMP inhibitors.

Chollet AM, Le Diguarher T, Kucharczyk N, Loynel A, Bertrand M, Tucker G, Guilbaud N, Burbridge M, Pastoureau P, Fradin A, Sabatini M, Fauchère JL, Casara P.

Bioorg Med Chem. 2002 Mar;10(3):531-44.

PMID:
11814839
27.

Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Design of a potent endozepine antagonist.

Leprince J, Oulyadi H, Vaudry D, Masmoudi O, Gandolfo P, Patte C, Costentin J, Fauchère JL, Davoust D, Vaudry H, Tonon MC.

Eur J Biochem. 2001 Dec;268(23):6045-57.

28.

[Study of methicillin-resistant Staphylococcus aureus colonization among intermediate-care facility patients].

Giret P, Roblot F, Poupet JY, Thomas P, Lussier-Bonneau MD, Pradère C, Becq-Giraudon B, Fauchère JL, Castel O.

Rev Med Interne. 2001 Aug;22(8):715-22. French.

PMID:
11534357
29.

Quality assessment of combinatorial pooled libraries using mass spectrometry.

Lambert PH, Bertin S, Fauchère JL, Volland JP.

Comb Chem High Throughput Screen. 2001 Jun;4(4):317-32.

PMID:
11472222
30.

[125I]-S36057: a new and highly potent radioligand for the melanin-concentrating hormone receptor.

Audinot V, Lahaye C, Suply T, Beauverger P, Rodriguez M, Galizzi JP, Fauchère JL, Boutin JA.

Br J Pharmacol. 2001 Jun;133(3):371-8.

31.

Parallel synthesis and pharmacological screening of nonpeptide ligands of the neuropeptide Y receptor subtype Y5.

Henlin JM, Boutin JA, Duchêne-Roger F, Nicolas JP, Desmet-Beaufort C, Levens N, Fauchère JL.

J Pept Res. 2001 May;57(5):419-27.

PMID:
11350602
32.

Structure-activity relationship studies of melanin-concentrating hormone (MCH)-related peptide ligands at SLC-1, the human MCH receptor.

Audinot V, Beauverger P, Lahaye C, Suply T, Rodriguez M, Ouvry C, Lamamy V, Imbert J, Rique H, Nahon JL, Galizzi JP, Canet E, Levens N, Fauchere JL, Boutin JA.

J Biol Chem. 2001 Apr 27;276(17):13554-62. Epub 2001 Jan 18.

33.
34.

From peptide libraries to optimized nonpeptide ligands in the search for S-farnesyltransferase inhibitors.

Henlin JM, Boutin JA, Kucharczyk N, Desmet-Beaufort C, Loynel A, Bertrand M, Genton A, Tucker GC, Atassi G, Fauchére JL.

J Pept Res. 2001 Feb;57(2):85-96.

PMID:
11168892
35.

[Effect of age on the prognosis of infectious endocarditis].

Paccalin M, Pasdeloup T, Cazenave-Roblot F, Ragot S, Breux JP, Raud-Raynier P, Fauchere JL, Corbi P, Roblot P, Becq-Giraudon B.

Arch Mal Coeur Vaiss. 2000 Sep;93(9):1083-7. French.

PMID:
11054998
36.

Helicobacter pylori and stomach cancer: a case-control study in Venezuela.

Plummer M, Vivas J, Fauchère JL, Del Giudice G, Peña AS, Ponzetto A, Lopez G, Miki K, Oliver W, Muñoz N.

Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):961-5.

37.

[Muco-cutaneous colonization and nosocomial infections caused by methicillin-resistant Staphylococcus aureus and Acinetobacter baumanii in intensive care patients].

Pasdeloup T, Caron F, Soyer S, Castel O, Aubenneau C, Fauchere JL, Robert R.

Pathol Biol (Paris). 2000 Jul;48(6):533-40. French.

PMID:
10965530
38.

Identification of the melatonin-binding site MT3 as the quinone reductase 2.

Nosjean O, Ferro M, Coge F, Beauverger P, Henlin JM, Lefoulon F, Fauchere JL, Delagrange P, Canet E, Boutin JA.

J Biol Chem. 2000 Oct 6;275(40):31311-7.

39.

Correlation between IL-8 induction, cagA status and vacA genotypes in 153 French Helicobacter pylori isolates.

Audibert C, Janvier B, Grignon B, Salaün L, Burucoa C, Lecron JC, Fauchère JL.

Res Microbiol. 2000 Apr;151(3):191-200.

PMID:
10865946
40.

Antibody response of patients with Helicobacter pylori-related gastric adenocarcinoma: significance of anti-cagA antibodies.

Vaucher C, Janvier B, Nousbaum JB, Grignon B, Pezennec L, Robaszkiewicz M, Gouerou H, Picard B, Fauchere JL.

Clin Diagn Lab Immunol. 2000 May;7(3):463-7.

41.

Food intake regulation in rodents: Y5 or Y1 NPY receptors or both?

Duhault J, Boulanger M, Chamorro S, Boutin JA, Della Zuana O, Douillet E, Fauchère JL, Félétou M, Germain M, Husson B, Vega AM, Renard P, Tisserand F.

Can J Physiol Pharmacol. 2000 Feb;78(2):173-85.

PMID:
10737680
42.

Substrate specificity and inhibition studies of human serotonin N-acetyltransferase.

Ferry G, Loynel A, Kucharczyk N, Bertin S, Rodriguez M, Delagrange P, Galizzi JP, Jacoby E, Volland JP, Lesieur D, Renard P, Canet E, Fauchère JL, Boutin JA.

J Biol Chem. 2000 Mar 24;275(12):8794-805. Erratum in: J Biol Chem 2000 Dec 15;275(50):39799.

43.

Screening of ligand binding on melatonin receptor using non-peptide combinatorial libraries.

Boutin JA, Lahaye C, Pegurier C, Nicolas JP, Fauchere JL, Langlois M, Renard P, Delagrange P, Canet E.

J Recept Signal Transduct Res. 2000 Jan;20(1):105-18.

PMID:
10711500
44.

Performance of native and recombinant antigens for diagnosis of Helicobacter pylori infection.

Widmer M, de Korwin JD, Aucher P, Thiberge JM, Suerbaum S, Labigne A, Fauchère JL.

Eur J Clin Microbiol Infect Dis. 1999 Nov;18(11):823-6.

PMID:
10614960
45.
46.

Nosocomial pneumonia with isolation of anaerobic bacteria in ICU patients: therapeutic considerations and outcome.

Robert R, Grollier G, Doré P, Hira M, Ferrand E, Fauchère JL.

J Crit Care. 1999 Sep;14(3):114-9.

PMID:
10527248
47.

Neuropeptide Y-induced contraction is mediated by neuropeptide Y Y2 and Y4 receptors in the rat colon.

Pheng LH, Perron A, Quirion R, Cadieux A, Fauchère JL, Dumont Y, Regoli D.

Eur J Pharmacol. 1999 Jun 11;374(1):85-91.

PMID:
10422644
48.

Phenotypic changes of Helicobacter pylori components during an experimental infection in mice.

Janvier B, Grignon B, Audibert C, Pezennec L, Fauchère JL.

FEMS Immunol Med Microbiol. 1999 May;24(1):27-33.

49.

Physico-chemical and biological analysis of true combinatorial libraries.

Boutin JA, Lambert PH, Bertin S, Volland JP, Fauchère JL.

J Chromatogr B Biomed Sci Appl. 1999 Apr 2;725(1):17-37. Review.

PMID:
10226875
50.

Investigation of S-farnesyl transferase substrate specificity with combinatorial tetrapeptide libraries.

Boutin JA, Marande W, Petit L, Loynel A, Desmet C, Canet E, Fauchère JL.

Cell Signal. 1999 Jan;11(1):59-69.

PMID:
10206346

Supplemental Content

Loading ...
Support Center